EUROFINS SCIENT Goodwill and Intangible Assets 2018-2025 | ERFSF
EUROFINS SCIENT goodwill and intangible assets from 2018 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
- EUROFINS SCIENT goodwill and intangible assets for the quarter ending June 30, 2025 were $6.091B, a 13.38% increase year-over-year.
- EUROFINS SCIENT goodwill and intangible assets for 2024 were $6.091B, a 5.24% increase from 2023.
- EUROFINS SCIENT goodwill and intangible assets for 2023 were $5.787B, a 0.92% increase from 2022.
- EUROFINS SCIENT goodwill and intangible assets for 2022 were $5.735B, a 3.26% decline from 2021.
| EUROFINS SCIENT Annual Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2024 | $6,091 |
| 2023 | $5,787 |
| 2022 | $5,735 |
| 2021 | $5,928 |
| 2020 | $4,968 |
| 2019 | $5,070 |
| 2018 | $5,155 |
| 2017 | $3,663 |
| 2016 | $0 |
| 2015 | $0 |
| EUROFINS SCIENT Quarterly Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2024-12-31 | $6,091 |
| 2023-06-30 | $5,859 |
| 2022-12-31 | $5,735 |
| 2021-12-31 | $5,928 |
| 2021-06-30 | $5,372 |
| 2020-12-31 | $4,968 |
| 2020-06-30 | $4,934 |
| 2019-12-31 | $5,070 |
| 2019-06-30 | $5,088 |
| 2018-12-31 | $5,155 |
| 2018-06-30 | $4,090 |
| 2017-12-31 | $3,663 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $14.857B | $7.522B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $149.755B | 27.77 |
| CVS Health (CVS) | United States | $83.583B | 10.39 |
| Elevance Health (ELV) | United States | $66.299B | 8.92 |
| Cencora (COR) | United States | $56.410B | 18.79 |
| DiDi Global (DIDIY) | China | $26.262B | 27.90 |
| Labcorp Holdings (LH) | United States | $22.648B | 18.00 |
| Natera (NTRA) | United States | $21.644B | 0.00 |
| BioMerieux (BMXMF) | France | $17.238B | 0.00 |
| ICON (ICLR) | Ireland | $14.237B | 13.70 |
| CochLear (CHEOY) | Australia | $13.302B | 0.00 |
| Medpace Holdings (MEDP) | United States | $13.148B | 34.80 |
| Solventum (SOLV) | United States | $12.897B | 13.31 |
| Viatris (VTRS) | United States | $12.137B | 4.32 |
| Revvity (RVTY) | United States | $10.554B | 18.59 |
| Caris Life Sciences,�Inc (CAI) | United States | $9.640B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.130B | 0.00 |
| Avantor (AVTR) | United States | $8.910B | 13.07 |
| HealthEquity (HQY) | United States | $7.720B | 33.81 |
| Charles River Laboratories (CRL) | United States | $7.628B | 14.47 |
| Bausch + Lomb (BLCO) | Canada | $5.016B | 33.74 |
| Sotera Health (SHC) | United States | $4.465B | 24.95 |
| BrightSpring Health Services (BTSG) | United States | $3.966B | 30.26 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.536B | 80.99 |
| Surgery Partners (SGRY) | United States | $3.021B | 38.00 |
| Concentras Parent (CON) | United States | $2.930B | 18.58 |
| Alignment Healthcare (ALHC) | United States | $2.923B | 0.00 |
| Organon (OGN) | United States | $2.433B | 2.65 |
| Premier (PINC) | United States | $2.020B | 15.33 |
| Progyny (PGNY) | United States | $1.983B | 41.93 |
| Ardent Health (ARDT) | United States | $1.813B | 7.00 |
| PACS (PACS) | United States | $1.750B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.350B | 9.01 |
| Teladoc Health (TDOC) | United States | $1.315B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.272B | 20.94 |
| Establishment Labs Holdings (ESTA) | $1.111B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.965B | 0.00 |
| Embecta (EMBC) | United States | $0.815B | 4.77 |
| AMN Healthcare Services Inc (AMN) | United States | $0.714B | 8.83 |
| CareDx (CDNA) | United States | $0.646B | 11.89 |
| Performant Healthcare (PHLT) | United States | $0.601B | 0.00 |
| Nutex Health (NUTX) | United States | $0.584B | 8.85 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 200.00 |
| So-Young (SY) | China | $0.517B | 0.00 |
| Omada Health (OMDA) | $0.517B | 0.00 | |
| InnovAge Holding (INNV) | United States | $0.494B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.489B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 10.50 |
| SBC Medicals (SBC) | United States | $0.447B | 9.81 |
| Agilon Health (AGL) | United States | $0.435B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.412B | 0.00 |
| Enhabit (EHAB) | United States | $0.384B | 25.23 |
| Oncology Institute (TOI) | United States | $0.366B | 0.00 |
| LifeMD (LFMD) | United States | $0.327B | 0.00 |
| Beauty Health (SKIN) | United States | $0.300B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.176B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.132B | 0.00 |
| KindlyMD (NAKA) | United States | $0.101B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.056B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.043B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.039B | 0.00 |
| ModivCare (MODV) | United States | $0.032B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |